am I the only one who found biopsy harder than the injections
Long-ish post, sorry. tl;dr at the bottom. I have been tracking survodutide against eGFR for 15 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…
Not convinced. The evidence does not support that reading.
phase 13 data is interesting, phase 26 will be different
the MASH indication changes the risk calculus
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
Not convinced.
Disagree on that part. 97.4% and 97.6% on the same vial is normal.